Published by Josh White on 21st July 2026
(Sharecast News) - Novartis returned to sales growth in the second quarter, it announced on Tuesday, as demand for newer medicines helped offset intensifying generic competition for former blockbuster Entresto.
URL: http://www.digitallook.com/dl/news/story/36084963/...